$SHRG
SHARING SERVICES GLOBAL Corp Stock $shrg

$shrg Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000149315223022193 Filed on June 23, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$2.900M	$3.364M	$16.10M
YoY Change	-45.32%	-45.99%	-53.22%
Cost Of Revenue	$845.8K	$1.786M	$6.845M
YoY Change	-48.96%	-18.66%	-36.63%
Gross Profit	$2.032M	$1.579M	$9.257M
YoY Change	-44.27%	-60.86%	-60.81%
Gross Profit Margin	70.08%	46.93%	57.49%
Selling, General & Admin	$3.709M	$4.560M	$24.07M
YoY Change	-49.26%	-47.47%	-34.86%
% of Gross Profit	182.48%	288.84%	260.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$178.2K	$187.3K	$583.4K
YoY Change	4.2%	-40.27%	-10.97%
% of Gross Profit	8.77%	11.86%	6.3%
Operating Expenses	$3.709M	$4.560M	$24.07M
YoY Change	-49.26%	-47.47%	-34.86%
Operating Profit	-$1.676M	-$2.982M	-$14.81M
YoY Change	-54.23%	-35.84%	11.12%
Interest Expense	$905.8K	$1.814M	$13.21M
YoY Change	-70.97%	-167.18%	-254.71%
% of Operating Profit
Other Income/Expense, Net	-$736.0K	-$4.964M	-$22.87M
YoY Change	-137.37%	-809.29%	-1094.22%
Pretax Income	-$2.412M	-$6.132M	-$37.69M
YoY Change	42.5%	-25.75%	87.09%
Income Tax	$12.10K	$789.8K
% Of Pretax Income
Net Earnings	-$2.424M	-$6.921M	-$37.69M
YoY Change	79.18%	77.31%	120.3%
Net Earnings / Revenue	-83.6%	-205.72%	-234.04%
Basic Earnings Per Share	-$0.01		-$0.14
Diluted Earnings Per Share	-$0.01	-$0.02	-$0.14
COMMON SHARES
Basic Shares Outstanding	376.3M shares	262.8M shares	274.1M shares
Diluted Shares Outstanding	370.9M shares		274.1M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.370M	$2.995M	$2.995M
YoY Change	-90.52%	-82.41%	-82.41%
Cash & Equivalents	$1.370M	$3.000M	$2.995M
Short-Term Investments
Other Short-Term Assets	$1.063M	$527.8K	$239.2K
YoY Change	-56.22%	-84.97%	-92.35%
Inventory	$1.478M	$1.636M	$1.925M
Prepaid Expenses
Receivables	$532.4K	$300.0K	$273.7K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.443M	$5.433M	$5.433M
YoY Change	-80.6%	-79.8%	-79.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$466.5K	$9.270M	$9.718M
YoY Change	-95.13%	-3.29%	-4.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$206.2K	$206.2K
YoY Change	-100.0%	-95.93%	-95.93%
Other Assets	$1.184M	$1.177M	$1.177M
YoY Change	594.04%	351.65%	244.36%
Total Long-Term Assets	$2.597M	$11.65M	$11.65M
YoY Change	-87.6%	-28.43%	-28.43%
TOTAL ASSETS
Total Short-Term Assets	$4.443M	$5.433M	$5.433M
Total Long-Term Assets	$2.597M	$11.65M	$11.65M
Total Assets	$7.041M	$17.08M	$17.08M
YoY Change	-83.94%	-60.43%	-60.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.001M	$1.029M	$7.951M
YoY Change	74.07%	4.4%	707.05%
Accrued Expenses	$5.282M	$6.190M	$6.190M
YoY Change	1291.69%	-14.92%	-14.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$24.66M	$24.83M	$24.83M
YoY Change	251.43%	150.81%	150.81%
Total Short-Term Liabilities	$31.23M	$39.36M	$39.36M
YoY Change	49.25%	101.85%	101.85%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$427.2K	$440.5K	$440.5K
YoY Change	-7.44%	-47.26%	-47.26%
Total Long-Term Liabilities	$427.2K	$440.5K	$440.5K
YoY Change	-7.44%	-47.26%	-47.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.23M	$39.36M	$39.36M
Total Long-Term Liabilities	$427.2K	$440.5K	$440.5K
Total Liabilities	$31.65M	$39.80M	$39.80M
YoY Change	44.31%	95.73%	95.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$108.9M	-$106.5M
YoY Change	83.83%	83.98%
Common Stock		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)		$626.2K
YoY Change
Treasury Stock Shares
Shareholders Equity	-$24.61M	-$22.72M	-$22.72M
YoY Change
Total Liabilities & Shareholders Equity	$7.041M	$17.08M	$17.08M
YoY Change	-83.94%	-60.43%	-60.43%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$2.424M	-$6.921M	-$37.69M
YoY Change	79.18%	77.31%	120.3%
Depreciation, Depletion And Amortization	$178.2K	$187.3K	$583.4K
YoY Change	4.2%	-40.27%	-10.97%
Cash From Operating Activities	-$1.789M	-$179.4K	-$9.025M
YoY Change	-52.63%	-91.24%	-40.73%
INVESTING ACTIVITIES
Capital Expenditures		-$207.6K	$1.196M
YoY Change		22.59%	-112.82%
Acquisitions
YoY Change
Other Investing Activities		$4.493M	-$5.634M
YoY Change		-1074.45%	60.42%
Cash From Investing Activities		$4.701M	-$6.830M
YoY Change		-845.63%	-46.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-4.583M	$1.919M
YoY Change		4724.16%	-94.18%
NET CHANGE
Cash From Operating Activities	-$1.789M	-179.4K	-$9.025M
Cash From Investing Activities		4.701M	-$6.830M
Cash From Financing Activities		-4.583M	$1.919M
Net Change In Cash	-$1.625M	-61.59K	-$14.03M
YoY Change	-36.77%	-97.78%	-385.82%
FREE CASH FLOW
Cash From Operating Activities	-$1.789M	-$179.4K	-$9.025M
Capital Expenditures		-$207.6K	$1.196M
Free Cash Flow	-$1.789M	$28.15K	-$10.22M
YoY Change	-54.28%	-101.5%	73.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q1	us-gaap	Notes Payable Current Related And Nonrelated Party Status Extensible Enumeration NotesPayableCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1	us-gaap	Notes Payable Current Related And Nonrelated Party Status Extensible Enumeration NotesPayableCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	SHRG	Settlement Liability Noncurrent SettlementLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2023	SHRG	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt		usd
CY2023	SHRG	Impairment Gain Loss On Assets ImpairmentGainLossOnAssets		usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001644488
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable		usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022	SHRG	Amortization Of Prepaid Consulting Fees AmortizationOfPrepaidConsultingFees		usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	SHRG	Noncash Consulting Expense NoncashConsultingExpense		usd
CY2023	us-gaap	Increase Decrease In Other Regulatory Assets IncreaseDecreaseInOtherRegulatoryAssets		usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2023	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	SHRG	Payment In Connection With Litigation Settlement PaymentInConnectionWithLitigationSettlement		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	SHRG	Loan Fees And Interest Obligations Settled With Shares Of Common Stock LoanFeesAndInterestObligationsSettledWithSharesOfCommonStock		usd
CY2023	SHRG	Rightofuse Assets Obtained In Exchange For Operating Lease Liability RightofuseAssetsObtainedInExchangeForOperatingLeaseLiability		usd
CY2023	SHRG	Investment Origination Fee Collected In Shares Of Investee Stock InvestmentOriginationFeeCollectedInSharesOfInvesteeStock		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q1	us-gaap	Property Plant And Equipment Useful Life Description Of Term Extensible Enumeration PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration	http://fasb.org/us-gaap/2023#UsefulLifeTermOfLeaseMember
CY2023Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2022Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2023	SHRG	Notes Receivable Writeoffs And Recoveries NotesReceivableWriteoffsAndRecoveries		usd
CY2023Q1	SHRG	Prepaid Consulting Fees PrepaidConsultingFees		usd
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2023Q1	SHRG	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment		usd
CY2021Q1	SHRG	Allowance For Impairment Losses AllowanceForImpairmentLosses		usd
CY2023	SHRG	Provision For Estimated Impairment Losses ProvisionForEstimatedImpairmentLosses		usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q1	us-gaap	Notes Payable Related And Nonrelated Party Status Extensible Enumeration NotesPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1	us-gaap	Notes Payable Related And Nonrelated Party Status Extensible Enumeration NotesPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent		usd
CY2023Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes		pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments		pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023Q1	SHRG	Deferred Tax Asset Liabilities Net DeferredTaxAssetLiabilitiesNet		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations		shares
CY2022	SHRG	Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023	SHRG	Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber		shares
CY2023Q1	SHRG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-55997
CY2023	dei	Entity Registrant Name EntityRegistrantName	SHARING SERVICES GLOBAL CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-0869786
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	5200 Tennyson Parkway
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 400
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Plano
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75024
CY2023	dei	City Area Code CityAreaCode	(469)
CY2023	dei	Local Phone Number LocalPhoneNumber	304-9400
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	1431059	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	376328885	shares
CY2023	dei	Auditor Firm AuditorFirmId	6121
CY2023	dei	Auditor Name AuditorName	Ankit Consulting Services, Inc.
CY2023	dei	Auditor Location AuditorLocation	Rancho Santa Margarita, California
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2994885	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17023266	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	273674	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1682958	usd
CY2022Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	300000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1636120	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	4374236	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	527827	usd
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3511282	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	5432506	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	26891742	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9270193	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9585141	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	448240	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	593389	usd
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	81205	usd
CY2023Q1	us-gaap	Investments Investments	206231	usd
CY2022Q1	us-gaap	Investments Investments	5063940	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	545372	usd
CY2022Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	688670	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1177173	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	260637	usd
CY2023Q1	us-gaap	Assets Assets	17079715	usd
CY2022Q1	us-gaap	Assets Assets	43164724	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1028510	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	985139	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2632770	usd
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3079782	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	2357643	usd
CY2022Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	3745481	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	148267	usd
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	452050	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1446503	usd
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1339366	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	6922043	usd
CY2023Q1	SHRG	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	24827086	usd
CY2022Q1	SHRG	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	9898770	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	39362822	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	19500588	usd
CY2022Q1	SHRG	Settlement Liability Noncurrent SettlementLiabilityNoncurrent	373677	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	440478	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	461515	usd
CY2023Q1	us-gaap	Liabilities Liabilities	39803300	usd
CY2022Q1	us-gaap	Liabilities Liabilities	20335780	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	26091136	shares
CY2022Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	26091136	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	626187	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	84619762	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	80738719	usd
CY2023Q1	SHRG	Shares To Be Issued SharesToBeIssued	12146	usd
CY2022Q1	SHRG	Shares To Be Issued SharesToBeIssued	12146	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106456378	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57886336	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-308305	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-65109	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-22723585	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	22828944	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17079715	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43164724	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16102136	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34424314	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6845466	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10801871	usd
CY2023	us-gaap	Gross Profit GrossProfit	9256670	usd
CY2022	us-gaap	Gross Profit GrossProfit	23622443	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6989660	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17239655	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17081915	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19714963	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	24071575	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	36954618	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-14814905	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-13332175	usd
CY2023	us-gaap	Interest Expense InterestExpense	13212583	usd
CY2022	us-gaap	Interest Expense InterestExpense	12204444	usd
CY2023	SHRG	Gain On Employee Warrants Liability GainOnEmployeeWarrantsLiability	173432	usd
CY2022	SHRG	Gain On Employee Warrants Liability GainOnEmployeeWarrantsLiability	2511350	usd
CY2022	SHRG	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	1040400	usd
CY2022	SHRG	Impairment Gain Loss On Assets ImpairmentGainLossOnAssets	-1610523	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-5018735	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3663940	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-4920556	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	108184	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-211035	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-22870258	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6810312	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37685163	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20142487	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3035990	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-37685163	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17106497	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	243196	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	65109	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-243196	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-65109	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37928359	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17171606	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	274108025	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	206211711	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	274108025	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	206211711	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-37685163	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17106497	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	726666	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	655267	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	-194004	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	-2120111	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1038359	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-25053	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10877730	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12231501	usd
CY2023	SHRG	Amortization Of Prepaid Consulting Fees AmortizationOfPrepaidConsultingFees	2867123	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	324229	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1040400	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2331554	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	162392	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-9939290	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	3663940	usd
CY2022	SHRG	Noncash Consulting Expense NoncashConsultingExpense	632877	usd
CY2023	SHRG	Provisions For Obsolete Inventory ProvisionsForObsoleteInventory	1788999	usd
CY2022	SHRG	Provisions For Obsolete Inventory ProvisionsForObsoleteInventory	635137	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1560481	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	163599	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1152522	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2579581	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	97073	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1098003	usd
CY2022	us-gaap	Increase Decrease In Other Regulatory Assets IncreaseDecreaseInOtherRegulatoryAssets	459	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	808008	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-304637	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	385013	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2110592	usd
CY2023	SHRG	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	25224	usd
CY2022	SHRG	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	-19073	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1043420	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2663745	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9025388	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15226654	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1196406	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9331967	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	313592	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	579790	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4920096	usd
CY2022	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	5000	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	400000	usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	2937000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6830094	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12843757	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	10922329	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	30000000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	4611342	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	100000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3270000	usd
CY2023	SHRG	Payment In Connection With Litigation Settlement PaymentInConnectionWithLitigationSettlement	1043645	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	78636	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3078607	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1918706	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32978607	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-91605	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-29339	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14028381	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4878857	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17023266	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12144409	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2994885	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17023266	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1708409	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	52541	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9525	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	47489	usd
CY2023	SHRG	Debt Modification DebtModification	10363126	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	552000	usd
CY2023	SHRG	Common Stock Issued To Settle Management Fees Payable CommonStockIssuedToSettleManagementFeesPayable	700000	usd
CY2022	SHRG	Loan Fees And Interest Obligations Settled With Shares Of Common Stock LoanFeesAndInterestObligationsSettledWithSharesOfCommonStock	8900000	usd
CY2022	SHRG	Rightofuse Assets Obtained In Exchange For Operating Lease Liability RightofuseAssetsObtainedInExchangeForOperatingLeaseLiability	523998	usd
CY2022	SHRG	Investment Origination Fee Collected In Shares Of Investee Stock InvestmentOriginationFeeCollectedInSharesOfInvesteeStock	500000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	6159039	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3000000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5400000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	21330000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	177879	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3780000	usd
CY2022	SHRG	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	153632	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	65109	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17106497	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	22828944	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	22828944	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	22828944	usd
CY2023	SHRG	Refinancing Of Debt And Detachable Warrants RefinancingOfDebtAndDetachableWarrants	2029454	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	652278	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-10363126	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	700000	usd
CY2023	SHRG	Stock Issued During Period Value Common Stock Issued To Settle Accrued Interest Payable StockIssuedDuringPeriodValueCommonStockIssuedToSettleAccruedInterestPayable	552000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	109780	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	243196	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-37685163	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-22723585	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-22723585	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16100000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34400000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-37700000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17100000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106500000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57900000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3000000.0	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	1800000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	635137	usd
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3511282	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zGbgAHZpGgYk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zS6fosvbVnub">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to the prior year’s data to conform with the current year’s presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_z2BA6Ae3X511" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zA2zOrPSGxuk">Use of Estimates and Assumptions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in accordance with GAAP requires the use of judgment and requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosures about contingent assets and liabilities, if any. Matters that require the use of estimates and assumptions include, among others: the recoverability of accounts and notes receivable, the valuation of inventory, the useful lives of fixed assets, the assessment of long-lived assets for impairment, the nature and timing of satisfaction of multiple performance obligations resulting from contracts with customers, the allocation of the transaction price to multiple performance obligations in a sales transaction, the measurement and recognition of right-of-use assets and related lease liabilities, the valuation of share-based compensation awards, the provision for income taxes, the measurement and recognition of uncertain tax positions, the valuation of long-term debt covenants, and the valuation of loss contingencies, if any. Actual results may differ from these estimates in amounts that may be material to our consolidated financial statements. We believe that the estimates and assumptions used in the preparation of our consolidated financial statements are reasonable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Credit Card Receivables CreditCardReceivables	500000	usd
CY2022Q1	us-gaap	Credit Card Receivables CreditCardReceivables	3300000	usd
CY2023Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	1300000	usd
CY2022Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	1400000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	300000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1700000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	71167	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	113896	usd
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	344071	usd
CY2023	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	5800000	usd
CY2022	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	16300000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	160225	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	13207	usd
CY2023	SHRG	Stock Based Compensation Fully Vested StockBasedCompensationFullyVested	173432	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2300000	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	186264	usd
CY2022	SHRG	Stock Based Compensation Fully Vested StockBasedCompensationFullyVested	2500000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8952555	usd
CY2022Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8976878	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1024274	usd
CY2023Q1	us-gaap	Investments Investments	206231	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	206231	usd
CY2023Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	24827086	usd
CY2023Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	24827086	usd
CY2022Q1	us-gaap	Investments Investments	5063940	usd
CY2022Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	5063940	usd
CY2022Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	5840000	usd
CY2022Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	5840000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-37685163	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17106497	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	274108025	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	206211711	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1338876599	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	234186020	shares
CY2023Q1	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	915112	usd
CY2022Q1	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	601520	usd
CY2023Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	915112	usd
CY2022Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	601520	usd
CY2022Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	601520	usd
CY2021Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	114599	usd
CY2023	SHRG	Notes Receivable Provision For Estimated Impairment Losses NotesReceivableProvisionForEstimatedImpairmentLosses	313592	usd
CY2022	SHRG	Notes Receivable Provision For Estimated Impairment Losses NotesReceivableProvisionForEstimatedImpairmentLosses	491921	usd
CY2022	SHRG	Notes Receivable Writeoffs And Recoveries NotesReceivableWriteoffsAndRecoveries	-5000	usd
CY2023Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	915112	usd
CY2022Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	601520	usd
CY2022Q1	SHRG	Allowance For Losses Current Assets AllowanceForLossesCurrentAssets	179765	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	527827	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2517046	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4482291	usd
CY2023Q1	SHRG	Allowance For Inventory Obsolescence AllowanceForInventoryObsolescence	880926	usd
CY2022Q1	SHRG	Allowance For Inventory Obsolescence AllowanceForInventoryObsolescence	108055	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1636120	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	4374236	usd
CY2022Q1	SHRG	Allowance For Inventory Obsolescence AllowanceForInventoryObsolescence	108055	usd
CY2021Q1	SHRG	Allowance For Inventory Obsolescence AllowanceForInventoryObsolescence	85058	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	1788999	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	635137	usd
CY2023	SHRG	Writeoffs And Recoveries WriteoffsAndRecoveries	-1016128	usd
CY2022	SHRG	Writeoffs And Recoveries WriteoffsAndRecoveries	-612140	usd
CY2023Q1	SHRG	Allowance For Inventory Obsolescence AllowanceForInventoryObsolescence	880926	usd
CY2022Q1	SHRG	Allowance For Inventory Obsolescence AllowanceForInventoryObsolescence	108055	usd
CY2022Q1	SHRG	Prepaid Consulting Fees PrepaidConsultingFees	2867123	usd
CY2023Q1	SHRG	Inventory Related Deposits InventoryRelatedDeposits	288649	usd
CY2022Q1	SHRG	Inventory Related Deposits InventoryRelatedDeposits	384477	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	167578	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	105652	usd
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	201275	usd
CY2023Q1	SHRG	Deposits For Sales Events DepositsForSalesEvents	120614	usd
CY2022Q1	SHRG	Deposits For Sales Events DepositsForSalesEvents	222540	usd
CY2023Q1	us-gaap	Contract With Customer Right To Recover Product Current ContractWithCustomerRightToRecoverProductCurrent	20975	usd
CY2022Q1	us-gaap	Contract With Customer Right To Recover Product Current ContractWithCustomerRightToRecoverProductCurrent	15632	usd
CY2023Q1	SHRG	Other Assets Current Gross OtherAssetsCurrentGross	703468	usd
CY2022Q1	SHRG	Other Assets Current Gross OtherAssetsCurrentGross	3691047	usd
CY2023Q1	SHRG	Allowance For Losses Current Assets AllowanceForLossesCurrentAssets	175641	usd
CY2022Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	875925	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	237042	usd
CY2022Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	237045	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	220264	usd
CY2022Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	223424	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	394306	usd
CY2022Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	263208	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10828441	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10576480	usd
CY2022Q1	SHRG	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment	100165	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1558248	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	891174	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9270193	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9585141	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	583369	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	534371	usd
CY2022Q1	SHRG	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment	100165	usd
CY2021Q4	us-gaap	Land Land	3675000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3700000	usd
CY2023	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	4900000	usd
CY2023Q1	SHRG	Investments Gross InvestmentsGross	1743231	usd
CY2022Q1	SHRG	Investments Gross InvestmentsGross	6600940	usd
CY2023Q1	SHRG	Allowance For Impairment Losses AllowanceForImpairmentLosses	1537000	usd
CY2022Q1	SHRG	Allowance For Impairment Losses AllowanceForImpairmentLosses	1537000	usd
CY2023Q1	us-gaap	Investments Investments	206231	usd
CY2022Q1	us-gaap	Investments Investments	5063940	usd
CY2023	SHRG	Schedule Of Allowances For Impairment Losses ScheduleOfAllowancesForImpairmentLosses	<p id="xdx_89E_ecustom--ScheduleOfAllowancesForImpairmentLosses_zCIKDMQ8BKH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reflects the activity in the allowance for impairment losses for the periods presented:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zpkmAyfEzyL9" style="display: none">SCHEDULE OF ALLOWANCE FOR IMPAIRMENT LOSSES</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20220401__20230331_zENoMdT7yFt4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20210401__20220331_zipyBFG7A8fh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year Ended March 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--AllowanceForImpairmentLosses_iS_zUANQf5H6Ka" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Balance at beginning of fiscal year</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,537,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1357">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--ProvisionForEstimatedImpairmentLosses_zsT2Pgzdpeif" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Provision for estimated impairment losses</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1359">-</span></span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,537,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--AllowanceForImpairmentLosses_iE_zmeBeujcXuo6" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance at end of fiscal year</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,537,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,537,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table>
CY2022Q1	SHRG	Allowance For Impairment Losses AllowanceForImpairmentLosses	1537000	usd
CY2022	SHRG	Provision For Estimated Impairment Losses ProvisionForEstimatedImpairmentLosses	1537000	usd
CY2023Q1	SHRG	Allowance For Impairment Losses AllowanceForImpairmentLosses	1537000	usd
CY2022Q1	SHRG	Allowance For Impairment Losses AllowanceForImpairmentLosses	1537000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	202779	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	6922043	usd
CY2021Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	1040400	usd
CY2021Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	8922	usd
CY2023	us-gaap	Payments For Loans PaymentsForLoans	418323	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10000000	usd
CY2022Q3	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	600000	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.08	pure
CY2022Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-08-12
CY2023Q1	us-gaap	Loans Payable LoansPayable	1500000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	54384	usd
CY2023Q1	SHRG	Deferred Sales Revenues DeferredSalesRevenues	246811	usd
CY2022Q1	SHRG	Deferred Sales Revenues DeferredSalesRevenues	547217	usd
CY2023Q1	SHRG	Liability Associated With Uncertain Tax Positions LiabilityAssociatedWithUncertainTaxPositions	925795	usd
CY2022Q1	SHRG	Liability Associated With Uncertain Tax Positions LiabilityAssociatedWithUncertainTaxPositions	921987	usd
CY2023Q1	SHRG	Accrued Interest Payable AccruedInterestPayable	536123	usd
CY2022Q1	SHRG	Accrued Interest Payable AccruedInterestPayable	26926	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	329762	usd
CY2022Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	478360	usd
CY2022Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	341919	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41385	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	134578	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	552894	usd
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	628795	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2632770	usd
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3079782	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	27000000	usd
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	30050000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-2172914	usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	20151230	usd
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	24827086	usd
CY2022Q1	us-gaap	Convertible Debt ConvertibleDebt	9898770	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	24827086	usd
CY2022Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	9898770	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2000000.0	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	448240	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	593389	usd
CY2023Q1	SHRG	Operating Lease Assets OperatingLeaseAssets	448240	usd
CY2022Q1	SHRG	Operating Lease Assets OperatingLeaseAssets	593389	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41385	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	134578	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	440478	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	461515	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	481863	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	596093	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	303157	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	585015	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	97977	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	100757	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	103536	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	106316	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	109095	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	196441	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	714122	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	232259	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	481863	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-2098199	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	100568	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-1997631	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1038359	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1038359	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3035990	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.005	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.067	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.013	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.151	pure
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	928525	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	972043	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	2	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	649113	usd
CY2023Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	661050	usd
CY2022Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	660904	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	215542	usd
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	141349	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1805119	usd
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2423409	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1805119	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2342204	usd
CY2022Q1	SHRG	Deferred Tax Asset Liabilities Net DeferredTaxAssetLiabilitiesNet	81205	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1800000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2300000	usd
CY2023Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	3809	usd
CY2022Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	17334	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	925786	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	921977	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	921977	usd
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	904643	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3809	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	17334	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	925786	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	921977	usd
CY2022Q1	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	121790	usd
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.20
CY2021Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	27000000.0	shares
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	38300000	shares
CY2023	SHRG	Liability Settlement Amount LiabilitySettlementAmount	2.0	usd
CY2022	SHRG	Liability Settlement Amount LiabilitySettlementAmount	715596	usd
CY2023	SHRG	Consulting Income ConsultingIncome	50000	usd
CY2022	SHRG	Consulting Income ConsultingIncome	33000	usd
CY2023Q1	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	2200000000	shares
CY2023Q1	SHRG	Capital Stock Par Or Stated Value Per Share CapitalStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	SHRG	Loan Origination Fee Shares LoanOriginationFeeShares	15000000.0	shares
CY2021Q2	SHRG	Prepayment Of Interest Shares PrepaymentOfInterestShares	12000000.0	shares
CY2021Q2	SHRG	Deemed Dividend Related Party Transaction DeemedDividendRelatedPartyTransaction	1100000	usd
CY2021Q4	SHRG	Deemed Dividend Related Party Transaction DeemedDividendRelatedPartyTransaction	2300000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2000000.0	usd
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	38300000	shares
CY2021	SHRG	Sharebased Compensation Arrangement By Sharebased Value Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedValuePaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	3600000	usd
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	10333333	shares
CY2021Q1	SHRG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.20
CY2022	SHRG	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2	P2Y3M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	250000000	shares
CY2022	SHRG	Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Granted In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedInPeriodWeightedAverageExercisePrice	0.14
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	50000000	shares
CY2022	SHRG	Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	0.0001
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	210333333	shares
CY2022Q1	SHRG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.18
CY2023	SHRG	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M6D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	818181819	shares
CY2023	SHRG	Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Granted In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedInPeriodWeightedAverageExercisePrice	0.033
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	1028515152	shares
CY2023	SHRG	Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice	0.06
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	8444663	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	109780	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	25624663	shares
CY2023Q1	SHRG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	23749663	shares
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16102136	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34424314	usd
CY2023	us-gaap	Gross Profit GrossProfit	9256670	usd
CY2022	us-gaap	Gross Profit GrossProfit	23622443	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6989660	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17239655	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17081915	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19714963	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-14814905	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-13332175	usd
CY2023Q1	us-gaap	Assets Assets	17079715	usd
CY2022Q1	us-gaap	Assets Assets	43164724	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1196406	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9331967	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	726666	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	655267	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16102136	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34424314	usd
CY2023Q1	us-gaap	Assets Assets	17079715	usd
CY2022Q1	us-gaap	Assets Assets	43164724	usd

Files In Submission

Name	View Source	Status
0001493152-23-022193-index-headers.html	Edgar Link	pending
0001493152-23-022193-index.html	Edgar Link	pending
0001493152-23-022193.txt	Edgar Link	pending
0001493152-23-022193-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
shrg-20230331.xsd	Edgar Link	pending
shrg-20230331_lab.xml	Edgar Link	unprocessable
shrg-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
shrg-20230331_def.xml	Edgar Link	unprocessable
shrg-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHRG
SHARING SERVICES GLOBAL Corp Stock $shrg

2023 Q2 Form 10-K Financial Statement

#000149315223022193 Filed on June 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHRG SHARING SERVICES GLOBAL Corp Stock $shrg

2023 Q2 Form 10-K Financial Statement

#000149315223022193 Filed on June 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHRG
SHARING SERVICES GLOBAL Corp Stock $shrg